Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-065617
Filing Date
2011-11-17
Accepted
2011-11-17 16:18:52
Documents
1
Period of Report
2011-11-16

Document Format Files

Seq Description Document Type Size
1 form445973_20111117041844-.html 4  
1 form445973_20111117041844-.xml 4 6521
  Complete submission text file 0001144204-11-065617.txt   7842
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address IMMUCELL CORP 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
BRIGHAM MICHAEL F (Reporting) CIK: 0001136544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 111213238